HIV Care and Coronavirus (COVID-19): The Latest Info and Guidance
Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.
Investigational PrEP Injection, Dosed Every Other Month, Holds Up Against Daily PrEP in Phase 3 Study
The long-acting injectable drug cabotegravir proved non-inferior to daily oral TDF/FTC for MSM and transgender women.
Could COVID-19 Contact Tracing Also Help End HIV? These Researchers Think So.
Some advocates support it but want to ensure protections against criminalization.
This Week in HIV Research: PrEP So White
May 21, 2020: PrEP demographics by health insurance claim data; pediatricians call for better PrEP formulations for teens; weight gain after switching from TDF to TAF; two-drug regimen efficacy when baseline viral load is high.
Our Newest Posts
Are Providers Ignoring Anal Sex as a Health Care Issue for Women at Risk for HIV and Cancer?
Recent studies examine the role anal sex is playing in HIV rates and anal cancer among women.
This Week in HIV Research: The Challenges of Our Assumptions
May 28, 2020: Anal lesion recurrence among women with HIV; non-alcoholic fatty liver disease frequency in lean patients; long-term efficacy for a smoking cessation intervention; non-lymphoid cancers following lymphoid malignancy.
After Years of Decline, Perinatal HIV Transmission Has Hit a Plateau. Why?
This researcher has some ideas about what we need to do to address the problem.
How to End COVID-19 and Other Pandemics With a Human Rights and Health Justice Approach
Natalia Linos, Sc.D., M.Sc., of Harvard University’s FXB Center for Health and Human Rights, calls for protections for low-wage essential workers and releasing people from jails, prisons, and ICE detention.
Evaluating PrEP Uptake and Adherence in Cisgender Women—and What to Do About It
Two researchers discuss their analysis of Philadelphia FIGHT’s HIV pre-exposure prophylaxis (PrEP) program for cisgender women.
CDC Issues New Guidance for Easier PrEP Access During COVID-19
Home HIV and STI testing is now being endorsed by the Centers for Disease Control and Prevention to start or continue pre-exposure prophylaxis (PrEP).
Refer your clients and patients to TheBody, TheBodyPro's sibling site for people living with or affected by HIV. TheBody delivers vital information, news, support, and personal perspectives on HIV and related issues.
